How to Buy Ani Pharmaceuticals Stock
Ani Pharmaceuticals Inc
ANI Pharmaceuticals, Inc. , a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
Ani Pharmaceuticals stock last closed at $68.00, down 1.75% from the previous day, and has increased 3.63% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.6 percentage points. Ani Pharmaceuticals stock is currently +29.52% from its 52-week low of $52.50, and -3.52% from its 52-week high of $70.48.
As of Apr 21, 2025, there are 21.77M shares of ANIP outstanding. The market value of ANIP is $1.48B. In the last 24 hours, 191,445 ANIP shares were traded.
How to Buy Ani Pharmaceuticals Stock
Wondering how to invest in Ani Pharmaceuticals stock? Here's how.
- Figure out where to buy Ani Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Ani Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Select your method of payment and add your details.
- Analyze Ani Pharmaceuticals stock: The Ani Pharmaceuticals ticker symbol is ANIP. Is Ani Pharmaceuticals stock a good investment? Should you buy shares of ANIP? How do ANIP's underlying business fundamentals look? Do top analysts think Ani Pharmaceuticals is a good buy? Why has ANIP's stock price moved recently? (Hint: Our stock market analysis website can help you understand if ANIP is a good stock to buy).
- Execute your ANIP purchase: Decide if you will purchase ANIP shares at the current market price or use a limit order to purchase ANIP stock at a given price.
- Keep an eye on your ANIP investment: Create a watchlist to get the latest news on your investment in Ani Pharmaceuticals stock.
Step 1: Figure out where to buy Ani Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy ANIP shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal info so you are able to buy ANIP today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new brokerage account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on the best stock app, you need to deposit funds:
Watch the walkthrough below if you need help transferring money into your brokerage account.
Step 4: Analyze Ani Pharmaceuticals stock
After you have chosen the best place to buy Ani Pharmaceuticals stock, it's critical to research their stock before you invest, so you actually understand the risk as well as the opportunity.
Ani Pharmaceuticals stock at a glance
Ani Pharmaceuticals Due Diligence Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on ANIP's stock page.
Is ANIP stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge ANIP's true value.
Using relative valuations ratios:
- ANIP may be overvalued based on its P/B ratio of 3.67x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.98x
You can do more valuation analysis on ANIP's stock here.
ANIP Financial Health
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the ANIP balance sheet.
Negative Health Checks:
- Total ANIP debt is higher than 5 years ago, relative to shareholder equity.
- ANIP profit margin has gone down from 3.5% to -3.3% in the past year.
- There are more long-term liabilities than short-term assets on the ANIP balance sheet.
- ANIP has a relatively high debt to equity ratio of 2.12.
- ANIP earnings of -$4.61M is not sufficient to cover its interest payments.
- ANIP's operating cash flow of $64.02M allows it to safely service it's debt of $624.09M.
Is it a good time to buy ANIP stock, according to analysts?
Out of 6 Wall Street analysts who track ANIP, the consensus analyst rating on ANIP is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent ANIP Analyst Ratings
Faisal Khurshid, a bottom 10% analyst from Leerink Partners initiates coverage on ANIP with a buy rating and announces their ANIP price target of $80.00, on Dec 11, 2024.
You can dive deeper into what analysts are projecting on the Ani Pharmaceuticals stock forecast page.
ANIP Trading Indicators
Is ANIP Making Money?
Last year, ANIP revenue was $614.38M. In the past five year, ANIP's revenue has gone up by 24.36% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.89%.
You can research ANIP's earnings and revenue performance here.
Who is buying/selling ANIP?
In the past 12 months, executives and large shareholders at ANIP have sold more shares than they have bought.
Meredith Cook, SR. VP GENERAL COUNSEL SEC. of ANIP, was the latest ANIP insider to sell. They sold $27,584.00 worth of ANIP shares on Apr 14, 2025.
Get more info about who owns ANIP shares here.
Does ANIP stock generate passive income?
No, Ani Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your ANIP purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount, place a limit order.
Click the Open button and your broker will place the order.
If you need additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your ANIP investment
Now that you own some ANIP stock, you'll want to keep up with your new shares.
Make a watchlist to monitor your ANIP stock.
ANIP Feed
How to Buy Stock in Ani Pharmaceuticals
To summarize, here are the 6 steps for buying Ani Pharmaceuticals stock:
- Figure out where to buy Ani Pharmaceuticals stock
- Create a brokerage account
- Fund your brokerage account
- Analyze Ani Pharmaceuticals stock
- Execute your ANIP purchase
- Keep an eye on your ANIP investment
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to track your new investment in Ani Pharmaceuticals, add ANIP to your watchlist by clicking the button below.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.